Palliative onkologische Chirurgie am oberen Verdauungstrakt - Stellenwert in Zeiten multimodaler Therapiekonzepte?

Zusammenfassung

Der Stellenwert palliativer Chirurgie bei Tumoren des oberen Gastrointestinaltraktes wird in erster Linie relativiert durch endoskopische und perkutan interventionelle Verfahren. Damit kann bei Ösophagus-, Pankreas- und Gallengangskarzinomen in der überwiegenden Mehrzahl der Patienten eine gute Palliation mit niedrigem Risiko erreicht werden. Die Indikation zur palliativen Resektion ist beim Magenkarzinom weiter zu stellen, da das perioperative Risiko geringer ist und die palliativen Effekte bei Blutung, Stenose, Tumorzerfall und Perforation insbesondere bei einer Lebenserwartung von noch ca. 6 Monaten besser sind. Die neoadjuvante Radio-/Chemotherapie verändert den Wert der palliativen Chirurgie bei oben genannten Tumoren nur in dem Maße wie die lokale R0-Resektionsrate gesteigert werden kann. Diese Effekte sind zur Zeit beim Ösophaguskarzinom am deutlichsten. Bis erfolgreiche kurative Behandlungen für Patienten mit fortgeschrittenen Tumoren verfügbar sind, müssen palliative Verfahren weiter verbessert und adäquat angewendet werden.

Abstract

The significance of palliative surgery for tumors of the upper gastrointestinal tract is mainly restricted by endoscopic and percutaneous interventional procedures. By these means a good palliation with low risk can be achieved in the majority of patients with oesophageal, pancreatic and biliary carcinomas. In gastric cancer the indication for palliative resection is more extensive because the perioperative risk is lower and the palliative effects in case of bleeding, stenosis, tumor necrosis and perforation especially for patients with a life expectancy of about 6 months are more favourable. Neoadjuvant radio-/chemotherapy changes the significance of palliative surgery in upper GI-tumors only to the extent that the local R0-resection rate can be increased. Currently these effects are most significant in oesophageal cancer. Until effective treatments for advanced staged patients become available, palliative procedures must be further improved and appropriately implemented.

Palliative Chirurgie - oberer Verdauungstrakt - Malignome - multimodale Krebstherapie

Palliative treatment - oncologic surgery - upper gastrointestinal tract - multimodal cancer therapy

Literatur

• 1 Hölscher A H. Das Radikalitätsprinzip in der operativen Therapie solider Tumoren des Gastrointestinaltraktes. Beger HG, Schwarz A, Brückner UB, Hartel W Forschung in der Chirurgie. Springer, Berlin - Heidelberg - New York 1997: 115-125
• 2 Siewert J R. Praxis der Visceralchirurgie. Onkologische Chirurgie. Springer, Berlin - Heidelberg - New York 2001
• 3 Hölscher A H, Metzger R, Schneider P M. Präoperative Radiochemotherapie des Ösophaguskarzinoms - Licht am Ende des Tunnels?.  Zentralbl Chir. 2000;  125 319-325
• 4 Aulbert E, Zech D. Lehrbuch der Palliativmedizin. Schattauer Verlag, Stuttgart - New York 1997
• 5 Rice D, Geller A, Benda C E, Gostout C J, Donohue J H. Surgical and interventional palliative treatment of upper gastrointestinal malignancies.  Eur J Gastroenterol Hepatol. 2000;  12 403-408
• 6 Kubba A K, Grasner N. An update in the palliative management of malignant dysphagia.  Eur J Surg Oncol. 2000;  26 116-129
• 7 Lerut T, de Leyn P, Coosemans W, van Raemdonck D, Cuypers P, van Cleyenbreughel B. Advanced esophageal cancer.  World J Surg. 1994;  18 379-387
• 8 Cox J, Bennett J R. Light at the end of the tunnel? Palliation for esophageal carcinoma.  Gut. 1987;  28 781-785
• 9 Segalin A, Little A G, Ruol A, Ferguson M K, Bardini R, Norberto L. et al . Surgical and endoscopic palliation of esophageal carcinoma.  Ann Thor Surg. 1989;  48 267-271
• 10 Pichelmaier H, Krüger I. Palliative allgemeinchirurgische Eingriffe. Aulbert E, Zech D Lehrbuch der Palliativmedizin. Schattauer Verlag, Stuttgart - New York 1997: 175-194
• 11 Gall C A, Rieger N A, Wattchow D A. Positive proximal resection margins after resection for carcinoma of the oesophagus and stomach: effect on survival and symptom recurrence.  Aust NZ J Surg. 1996;  66 734-737
• 12 Meijer S, de Bakker O JGB, Hoitsma H FW. Palliative resection in gastric cancer.  J Surg Oncol. 1983;  23 77-80
• 13 Ekbom G A, Gleysteen J J. Gastric malignancy: resection for palliation.  Surgery. 1980;  88 476-481
• 14 Haugstveldt T, Viste A, Eide G E, Real C, Soreide O. The survival benefit of resection in patients with advanced stomach cancer: the Norwegian multicenter experience.  World J Surg. 1989;  13 617-622
• 15 Bonzetti F, Bonfanti G, Audisio R A, Doci R, Dossena G, Gennari L, Andreola S. Prognosis of patients after palliative surgical procedures for carcinoma of the stomach.  Surg Gyn Obstet. 1987;  164 151-154
• 16 Butler J, Dubrow T J, Trezona T, Klassen M, Nejdt R J. Total gastrectomy in the treatment of advanced gastric cancer.  Am J Surg. 1989;  159 602-605
• 17 Monson J RT, Donohue J H, Mac Illrath D C, Farnell M B, Ilstrup D M. Total gastrectomy for advanced cancer.  Cancer. 1991;  68 1863-1868
• 18 Hallissey M T, Allum W H, Roginski C, Fielding J WL. Palliative surgery for gastric cancer.  Cancer. 1988;  62 440-444
• 19 Adachi Y, Mori M, Maehara Y, Matsumata T, Okudaira Y, Sugimachi K. Surgical results of perforated gastric carcinoma: an analysis of 155 Japanese patients.  Am J Gastroenterol. 1997;  92 516-518
• 20 Gertsch P, Chow L WC, Yuen S T, Chau K Y, Lauder U. Long-term survival after gastrectomy for advanced bleeding or perforated gastric carcinoma.  Eur J Surg. 1996;  162 723-727
• 21 Bonenkamp J J, Sasako M, Hermanns J, van de Velde C JH. Tumor load and surgical palliation in gastric cancer.  Hepatogastroenterol. 2001;  48 1219-1221
• 22 Sugarbaker P H, Yonemura Y. Palliation with a glimmer of hope: management of resectable gastric cancer with peritoneal carcinomatosis.  Hepatogastroenterol. 2001;  48 1238-1247
• 23 Miyamoto M, Sudo T, Kuyama T. Spontaneous rupture of hepatocellular carcinoma: a review of 172 Japanese cases.  Am J Gastroenterol. 1991;  86 67-71
• 24 Lai E CS, Wu K M, Choi T K, Fan S T, Wong J. Spontaneous rupture in hepatocellular carcinoma.  Ann Surg. 1989;  210 24-28
• 25 Xu H S, Yan J B. Concervative management of spontaneous ruptured hepatocellular carcinoma.  Am Surg. 1994;  60 629-633
• 26 Majno P E, Adam R, Bismuth H. Influence of preoperative transarterial lipiodol chemoembolisation on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis.  Ann Surg. 1998;  226 688-692
• 27 Guthrie C M, Haddock G, de Beaux A C, Garden O J, Carter D C. Changing trends in the management of extrahepatic cholangiocarcinoma.  Br J Surg. 1993;  80 1434-1439
• 28 Lillemoe K D, Pitt H A, Kaufman S L, Cameron J L. Acute cholecystitis: a complication of percutaneous transhepatic drainage.  Surg Gyn Obstet. 1989;  168 348-352
• 29 Beckurts K TE, Hölscher A H, Bauer T, Siewert J R. Maligne Tumoren der Hepatikusgabel - Ergebnisse der chirurgischen Therapie und Prognosefaktoren.  Chirurg. 1997;  68 378-384
• 30 Bismuth H, Castaing D, Traynor O. Resection or palliation: priority of surgery in the treatment of hilar cancer.  World J Surg. 1988;  12 39-47
• 31 Reding R, Buard J L, Lebeau G, Launois B. Surgical management of 552 carcinomas of the extrahepatic bile ducts (gallbladder and periampullary tumors excluded).  Ann Surg. 1991;  213 236-241
• 32 Washburn K, Lewis W D, Jenkins R L. Aggressive surgical resection for cholangiocarcinoma.  Arch Surg. 1995;  130 270-276
• 33 Kosuge T, Yamanota J, Shimada K. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection.  Ann Surg. 1999;  230 663-671
• 34 McMasters K M, Tuttle T M, Leach S D. Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma.  Am J Surg. 1997;  98 752-759
• 35 Watanapa P, Williamson R CN. Surgical palliation for pancreatic cancer: developments during the past two decades.  Br J Surg. 1992;  79 8-20
• 36 Potts J R, Broughan T A, Hermann P E. Palliative operations for pancreatic cancer.  Am J Surg. 1990;  159 72-78
• 37 Targarona E M, Pera M I, Martinez J, Balague C, Trias M. Laparoscopic treatment of pancreatic disorders: diagnosis and staging, palliation of cancer and treatment of pancreatic pseudocysts.  Int Surg. 1996;  81 1-5
• 38 Sarfehy U, Rypins E B, Jakowatz J G, Juler G L. A prospective, randomized clinical investigation of cholecystoenterostomy and choledochoenterostomy.  Am J Surg. 1988;  155 411-414
• 39 Bakkevold K E, Kambestad B. Morbidity and mortality after radical and palliative pancreatic cancer surgery.  Ann Surg. 1993;  217 356-368
• 40 Huguier M, Baumel H, Manderscheid J C, Houry S, Fabre J M. Surgical palliation for unresected cancer of the exocrine pancreas.  Eur J Surg Oncol. 1993;  19 342-347
• 41 Bajetta E, di Bartholomeo M, Stani S C. Chemoradiotherapy vs preoperative treatment in locally advanced unresectable pancreatic cancer patients: results of a feasibility study.  Int J Radiat Oncol Biol Phys. 1999;  45 285-289
• 42 Spitz F R, Abbruzzese J L, Lee J E. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas.  J Clin Oncol. 1997;  15 928-937